St. Jude Medical Inc.
(STJ:NYSE)
Snapshot of St. Jude Medical Inc. (STJ)
|
OPEN
$34.32
|
PREVIOUS CLOSE
$34.32
|
|
|
DAY HIGH
$35.11
|
DAY LOW
$34.32
|
|
|
52 WEEK HIGH
06/29/09 - $41.96
|
52 WEEK LOW
12/1/08 - $25.00
|
|
|
MARKET CAP
11.7B
|
AVERAGE VOLUME 3 mo
3.2M
|
|
|
DILUTED EPS TTM
$1.12
|
SHARES OUTSTANDING
334.3M
|
|
|
STJ Does Not Pay Dividends
|
P/E TTM
31.2x
|
|
| K = Thousands M = Millions B = Billions | ||
related business week news
Major indexes extended Tuesday's advance amid optimism over third-quarter earnings. Dollar weakness pushed gold to a record high
With the Merlin.net network, cardiac device maker St. Jude takes on market leader Medtronic in wireless patient-care networks
The maker of cardiac rhythm management products is anticipating rising demand overseas, and at home has a robust balance sheet and cash flow
Indexes recovered from earlier losses amid speculation about a "white knight" for troubled firm Lehman Brothers
related news
STJ Details
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart back to the device. The Cardiovascular segment provides mechanical and tissue replacement heart valves, as well as heart valve repair products. It also offers disposable interventional devices, including vascular closure devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters. The Atrial Fibrillation segment provides a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It offers electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, including rechargeable implantable pulse generators, conventional implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
STJ Top Compensated Officers
No compensation data is available at this time for the top officers at this company.
Key developments for St. Jude Medical Inc. (STJ)
St. Jude Medical Inc. - Conference Presentation Calls
St. Jude Medical Inc. expected to Report Fiscal Year 2009 Results on January 25, 2010. This event was calculated by Capital IQ (Created on October 30, 2009).
Joseph McCullough has notified St. Jude Medical Inc. of his decision to step down from his role as Group President of the Company effective November 1, 2009 and his intent to retire from the Company. As a result, Michael Rousseau, Group President, will assume responsibility for the Company's United States Division, which he previously led from January 2002 to January 2008. The Cardiac Rhythm Management Division will continue to report to Mr. Rousseau.
BusinessWeek Rankings
Stock Quotes
| Recently Viewed | |||
| STJ | $35.01 USD | +0.69 |  |
|---|---|---|---|
| TCB | $12.66 USD | +0.26 |  |
| WIT | $20.63 USD | +0.15 |  |
| HRB | $20.65 USD | +0.27 |  |
| AMGN | $56.25 USD | +0.87 |  |
Market data is delayed at least 20 minutes.
STJ Competitors
| Company | Last | Change |
| Boston Scientific Corp | $8.16 USD | +0.07 |
| CR Bard Inc | $81.00 USD | +0.28 |
| Henry Schein Inc | $51.62 USD | +1.09 |
| Omnicare Inc | $23.67 USD | +0.42 |
| PSS World Medical Inc | $19.83 USD | +0.15 |
| View Industry Companies | ||
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | STJ | Industry Range |
| Price/Earnings | 29.2x |
|
| Price/Sales | 2.6x |
|
| Price/Book | 3.3x |
|
| Price/Cash Flow | 28.0x |
|
| TEV/Sales | 1.9x |
|
|
STJ |
||
STJ transactions
| Type Date |
Target |
|
Bankruptcy
September 11, 2009 |
Fellowship Spine Surgical Center LLC |
|
Buyback
July 22, 2009 |
-- |
Companies Toolbox
Update/report
Submit private company
Upload your company video
Newsletter
Blogs
RSS feeds
Podcasts
VideosSEARCH FOR JOBS
Post a Job- Dallas, TX-St. Jude Medical- Dallas
- Dallas, TX-St. Jude Medical- Dallas
- Dallas, TX-St. Jude Medical- Dallas
- Dallas, TX-St. Jude Medical- Dallas
Jobs by SimplyHired
Recommend A Data Enhancement Or Correction
For St. Jude Medical Inc. (STJ) Snapshot
Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.
Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.
Please indicate which data is in error.
Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.
Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.
